With the analysis among 2,233 patents, we discovered top 390 key players by total patent application. Ono Pharmaceutical Co., Ltd., Bristol Myers Squibb Co., BeyondSpring Pharmaceuticals, Inc. are dominant in this area. They take 7.88% of the total patent filing.
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 77
New York, United States
Patent: 55
BeyondSpring Pharmaceuticals, Inc.
New York, United States
Patent: 44
Institut National de la Santé et de la Recherche Médicale
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 33
Tokyo-to, Japan
Patent: 32
California, United States
Patent: 26
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 26
Texas, United States
Patent: 26
New Jersey, United States
Patent: 25
With the analysis among 247 patents, we discovered top 37 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, GeneMedicine, GI Innovation, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
New Jersey, United States
Patent: 13
OrigiMed (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 12
Bayern, Germany
Patent: 12
California, United States
Patent: 12
California, United States
Patent: 11
Cambridgeshire, United Kingdom
Patent: 11
With the analysis among related 2,259 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Ono Pharmaceutical Co., Ltd., Institut National de la Santé et de la Recherche Médicale, The Board of Regents of The University of Texas System take 6.86% of patent filing during this period.
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 57
Institut National de la Santé et de la Recherche Médicale
The Board of Regents of The University of Texas System
Texas, United States
Patent: 48
New York, United States
Patent: 39
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 35
Tokyo-to, Japan
Patent: 32
Centre National De La Recherche Scientif
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 26
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 25
National Center For Child Health & Development
Tokyo-to, Japan
Patent: 23
With the analysis among related 2,259 patents in last 5 years, we discover 414 new entrants. National Cancer Center Korea, Astellas Pharma, Inc., Centre National De La Recherche Scientif are the most active new entrants in this area.
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 35
Tokyo-to, Japan
Patent: 32
Centre National De La Recherche Scientif
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 26
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 25
National Center For Child Health & Development
Tokyo-to, Japan
Patent: 23
Aargau, Switzerland
Patent: 20
SBI Pharmaceuticals Co., Ltd.
Tokyo-to, Japan
Patent: 19
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 16
With the analysis among 805 patents, we discovered top 110 universities and scientific research institutions by total patent application. University of Zurich, University of Basel, Duke University are dominant in this area. They take 21.61% of the total patent filing.
ZURICH, Switzerland
Patent: 35
Basel-Stadt, Switzerland
Patent: 29
North Carolina, United States
Patent: 28
The Johns Hopkins University
Connecticut, United States
Patent: 18
Kyoto-fu, Japan
Patent: 16
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 16
Université Toulouse III - Paul Sabatier
Miyagi-ken, Japan
Patent: 15
Osaka-fu, Japan
Patent: 14